Displaying Guidelines
1 Items
Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy
Document Status: Archived
ID: 12-3
ID: 12-3
Jan 2003
Cancer care is delivered by many different healthcare providers using a variety of methods to address a range of patient needs. The guidelines focus on care options for specific types of cancer, and are available within the following clinical areas: